Applied Filters
Children’s hospital researcher admits selling trade secrets to China
A former researcher at the research institute of the Nationwide Children’s Hospital in Ohio has pleaded guilty to conspiring to steal scientific trade secrets to sell in China.
Australian court affirms Mylan patent invalidation
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
Roche and Innovent unite in $2bn biospecifics deal
Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.
WHO launches COVID-19 pool with 37 countries
The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
Australia investigates counterfeit N95s in hospitals
The Australian government has ordered an investigation into the sale of counterfeit face masks in the country, following warnings from health experts and local media reports over the prevalence of fake equipment.
WHO and Costa Rica to launch COVID-19 technology patent pool
The World Health Organization and Costa Rica will launch a technology pooling initiative to help fight the COVID-19 pandemic.
Setback for Gilead in GSK HIV antiviral suit
An Australian federal judge has thrown out a challenge by Gilead Sciences to the wording of infringement claims made by a GlaxoSmithKline subsidiary.
Plant breeders facing ‘critical situation’ ask nations for support
The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.
US companies hit hardest by fake medicines: EUIPO, OECD
Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.
WHO to begin working on gene editing research registry
World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.
